Diloxanide Furoate is an antiprotozoal agent classified as a lumenal amebicide, primarily indicated for the treatment of intestinal amoebiasis caused by Entamoeba histolytica. Functioning exclusively within… Read more
Diloxanide Furoate is an antiprotozoal agent classified as a lumenal amebicide, primarily indicated for the treatment of intestinal amoebiasis caused by Entamoeba histolytica. Functioning exclusively within the gastrointestinal tract, the drug works by eradicating cysts and trophozoites rather than acting systemically. To support the rigorous demands of pharmaceutical manufacturing and research, this category provides access to high-quality reference standards of the active pharmaceutical ingredient, alongside its identified impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these reference materials for essential analytical testing, impurity profiling, and method validation during the quality control of pharmaceutical formulations. By utilizing these precise standards, researchers and analysts can accurately quantify impurities and ensure the safety and efficacy of final drug products throughout the development and manufacturing process.